Computomics and Hudson River Biotechnology Collaborate in Optimizing Plant Breeding with CRISPR
Computomics and Hudson River Biotechnology (HRB) will start offering AccelATrait™, a joint end-to-end solution using CRISPR-based gene editing for novel plant trait development. AccelATrait™ uses
Prof. Patricia Dankers joins Hudson River Biotechnology’s Scientific Advisory Board
Prof. Patricia Dankers, full professor of Biomedical Materials & Chemistry at the department of Biomedical Engineering and the Institute for Complex Molecular Systems of Eindhoven
Hudson River Biotechnology raises €5m Series A funding to accelerate growth of its plant gene editing business and expand into nanoparticles for use in field applications
Ferdinand Los, CSO at Hudson River Biotechnology: “We strongly believe in our ability to keep innovating and be at the forefront of technological developments. This
Opinion piece in Agfunder: A sole focus on organic farming will not get us where we need to be
In an opinion piece on AgFunder, our founders Rudi Ariaans and Ferdinand Los argue that CRISPR is the best tool the EU has to achieve its ambitious agrifood sustainability goals.
Company profile of Hudson River Biotechnology in Bionieuws
Bionieuws, the Dutch magazine for biologists interviewed our CSO Ferdinand Los, and published a short company profile in their magazine. Read the article here.
Prof. John van der Oost joins Hudson River Biotechnology’s Advisory Board
Prof. John van der Oost, head of the Bacterial Genetics group in the Laboratory of Microbiology at Wageningen University, has joined the Scientific Advisory Board
Hudson River Biotechnology (HRB) names Gabino Sánchez as Sales & Business Development Director.
>> download a pdf version of the press release
Hudson River Biotechnology named as one of the 15 most promising startups in Europe
>> download a pdf version of the press release